These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization. Goyanes A; Souto C; Martínez-Pacheco R Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708 [TBL] [Abstract][Full Text] [Related]
13. ¹³C solid-state NMR analysis of the most common pharmaceutical excipients used in solid drug formulations, Part I: Chemical shifts assignment. Pisklak DM; Zielińska-Pisklak MA; Szeleszczuk Ł; Wawer I J Pharm Biomed Anal; 2016 Apr; 122():81-9. PubMed ID: 26845204 [TBL] [Abstract][Full Text] [Related]
14. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein. Wen L; Zheng X; Wang X; Lan H; Yin Z Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430 [TBL] [Abstract][Full Text] [Related]
15. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms. Debotton N; Dahan A Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146 [TBL] [Abstract][Full Text] [Related]
16. Surface acidity and solid-state compatibility of excipients with an acid-sensitive API: case study of atorvastatin calcium. Govindarajan R; Landis M; Hancock B; Gatlin LA; Suryanarayanan R; Shalaev EY AAPS PharmSciTech; 2015 Apr; 16(2):354-63. PubMed ID: 25319055 [TBL] [Abstract][Full Text] [Related]
17. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization. Goyanes A; Souto C; Martínez-Pacheco R Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024 [TBL] [Abstract][Full Text] [Related]
18. Excipient variability and its impact on dosage form functionality. Dave VS; Saoji SD; Raut NA; Haware RV J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249 [TBL] [Abstract][Full Text] [Related]
19. Impact of excipient interactions on solid dosage form stability. Narang AS; Desai D; Badawy S Pharm Res; 2012 Oct; 29(10):2660-83. PubMed ID: 22707362 [TBL] [Abstract][Full Text] [Related]
20. Miniaturized approach for excipient selection during the development of oral solid dosage form. Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]